Prostatic stromal sarcoma with neuroectodermal differentiation.

Unlabelled: Prostatic stromal sarcoma is a fairly rare tumor that constitutes approximately 0.1-0.2% of all prostatic cancers.

[Anaphylactoid purpura after intravesical therapy using bacillus Calmette-Guerin for superficial bladder cancer].

We report a very rare side effect, anaphylactoid purpula, after intravesical administration of bacillus Calmette-Guerin (BCG). A 83-year-old man presented with purpura located on his bilateral lower legs. He had received transurethral resections four times for superficial bladder tumors.

[A case report of a terminally ill patient who achieved good pain control by pharmaceutical intervention in home terminal care].

We provided consultations with pharmacists to a terminally ill patient with radicular pain at his home. Before pharmaceutical intervention, the patient's compliance had been poor and consequently he had not achieved stable pain. The pharmacists suggested changes in the pharmacological and physical regimen that satisfied both the patient and his family.

[Superficial bladder cancer with lung metastasis without local invasion: a case report].

A 66-year-old woman presented with a coin-size lesion in the right lung. Bronchoalveolar lavage cytology showed class V. Thoracoscopic partial pneumonectomy of right upper lobe was performed and pathologic finding was metastatic transitional cell carcinoma (TCC).

[Subsequent upper urothelial cancer following bladder tumor].

A total of 110 patients were treated with primary transitional cell carcinoma (TCC) of the urinary bladder from 1990 to 2000. During the follow-up period, which was for at least two years, four patients (3.6 percent) had subsequent upper urothelial cancer at an average of 61.